Mp43-01 phase 2 keynote-057 study: pembrolizumab for patients with high-risk non–muscle invasive bladder cancer unresponsive to bacillus calmette-guerin

Journal of Urology(2019)

引用 1|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要